Gemmer Asset Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.16M Buy
8,495
+15
+0.2% +$3.5K 0.15% 59
2026
Q1
$2.07M Buy
8,480
+595
+8% +$139K 0.16% 57
2025
Q4
$1.63M Sell
7,885
-224
-3% -$44.3K 0.13% 66
2025
Q3
$1.5M Buy
8,109
+63
+0.8% +$10.8K 0.12% 66
2025
Q2
$1.23M Buy
8,046
+21
+0.3% +$3.23K 0.11% 71
2025
Q1
$1.33M Sell
8,025
-1,273
-14% -$199K 0.13% 64
2024
Q4
$1.34M Buy
9,298
+923
+11% +$143K 0.13% 64
2024
Q3
$1.36M Buy
8,375
+2,356
+39% +$375K 0.14% 62
2024
Q2
$880K Sell
6,019
-87
-1% -$12.9K 0.09% 68
2024
Q1
$966K Buy
6,106
+2
+0% +$318 0.11% 59
2023
Q4
$957K Buy
6,104
+51
+0.8% +$7.82K 0.12% 56
2023
Q3
$943K Sell
6,053
-183
-3% -$30.2K 0.13% 55
2023
Q2
$1.03M Sell
6,236
-1,123
-15% -$181K 0.14% 53
2023
Q1
$1.14M Buy
7,359
+36
+0.5% +$5.81K 0.17% 49
2022
Q4
$1.29M Sell
7,323
-102
-1% -$17.6K 0.2% 46
2022
Q3
$1.21M Buy
7,425
+158
+2% +$26.7K 0.2% 53
2022
Q2
$1.29M Sell
7,267
-489
-6% -$87.1K 0.2% 49
2022
Q1
$1.37M Buy
7,756
+9
+0.1% +$1.53K 0.17% 53
2021
Q4
$1.32M Sell
7,747
-249
-3% -$40.8K 0.16% 55
2021
Q3
$1.29M Buy
7,996
+502
+7% +$85.6K 0.18% 51
2021
Q2
$1.24M Sell
7,494
-102
-1% -$16.9K 0.17% 57
2021
Q1
$1.25M Buy
7,596
+453
+6% +$73.3K 0.2% 50
2020
Q4
$1.12M Buy
7,143
+426
+6% +$62.9K 0.19% 50
2020
Q3
$1M Buy
6,717
+22
+0.3% +$3.25K 0.19% 49
2020
Q2
$941K Sell
6,695
-74
-1% -$10.8K 0.2% 49
2020
Q1
$888K Sell
6,769
-34
-0.5% -$4.82K 0.24% 46
2019
Q4
$992K Sell
6,803
-526
-7% -$71.3K 0.23% 44
2019
Q3
$948K Sell
7,329
-135
-2% -$17.8K 0.24% 44
2019
Q2
$1.04M Sell
7,464
-3,115
-29% -$431K 0.28% 37
2019
Q1
$1.48M Buy
10,579
+5,089
+93% +$682K 0.4% 32
2018
Q4
$709K Sell
5,490
-6,488
-54% -$905K 0.22% 45
2018
Q3
$1.66M Buy
11,978
+348
+3% +$46.2K 0.51% 31
2018
Q2
$1.41M Sell
11,630
-3,982
-26% -$497K 0.49% 32
2018
Q1
$2M Buy
15,612
+1,129
+8% +$153K 0.69% 29
2017
Q4
$2.02M Buy
14,483
+2,254
+18% +$314K 0.7% 30
2017
Q3
$1.59M Buy
12,229
+1,983
+19% +$263K 0.6% 34
2017
Q2
$1.35M Buy
10,246
+3,060
+43% +$390K 0.57% 34
2017
Q1
$895K Buy
7,186
+1,764
+33% +$211K 0.4% 38
2016
Q4
$625K Buy
5,422
+404
+8% +$46.7K 0.31% 38
2016
Q3
$593K Buy
5,018
+250
+5% +$30.3K 0.3% 40
2016
Q2
$578K Buy
4,768
+56
+1% +$6.36K 0.31% 40
2016
Q1
$509K Sell
4,712
-309
-6% -$32K 0.3% 41
2015
Q4
$516K Sell
5,021
-500
-9% -$50.3K 0.3% 39
2015
Q3
$515K Sell
5,521
-129
-2% -$12.5K 0.33% 38
2015
Q2
$551K Buy
5,650
+35
+0.6% +$3.5K 0.33% 36
2015
Q1
$565K Sell
5,615
-172
-3% -$17.5K 0.34% 36
2014
Q4
$605K Sell
5,787
-64
-1% -$6.74K 0.41% 31
2014
Q3
$624K Buy
5,851
+255
+5% +$26.4K 0.44% 35
2014
Q2
$585K Sell
5,596
-26
-0.5% -$2.63K 0.39% 40
2014
Q1
$552K Buy
+5,622
New +$521K 0.39% 37

Other funds holding JNJ

Gemmer Asset Management's JNJ Position: Q2 2026 in Review

Gemmer Asset Management increased its Johnson & Johnson (JNJ) stake by 0.18% in Q2 2026, buying an estimated $3.5K and bringing the position to 8,495 shares worth $2.16M. The position accounts for 0.15% of the portfolio, ranked #59.

Gemmer Asset Management first reported a position in JNJ in Q1 2014 and has held it in 50 quarters since. 4,665 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Gemmer Asset Management held 8,495 shares of Johnson & Johnson worth $2.16M as of Q2 2026.
  • Gemmer Asset Management bought 15 Johnson & Johnson shares in Q2 2026, an estimated $3.5K.
  • Johnson & Johnson made up 0.15% of Gemmer Asset Management's portfolio in Q2 2026, its #59 holding.
  • Gemmer Asset Management first reported a position in Johnson & Johnson in Q1 2014 and has held it in 50 quarters since.
  • 4,665 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Gemmer Asset Management's 13F filing for Q2 2026, filed 15 Jul 2026.